Jiang Xiao-dan, Li Guang-yu, Sha Ji-chao, Zhu Xue-wei, Meng Cui-da, Dong Zhen, Zhu Dong-dong
Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Aug;45(8):652-5.
To evaluate the correlation between two serum specific IgE and skin prick test (SPT) for the diagnosis of allergic rhinitis.
Two hundred and sixteen patients were referred to the allergist for a suspected allergic rhinitis between June and October in 2009. Patients were classified as positive for inhalant allergy if they had a positive clinical history and a related positive SPT for the suspected inhalant allergen. Statistical analysis was performed using SPSS13.0 software.
One hundred and fifty-eight patients had a positive SPT, comparing with the SPT, the diagnostic indexes (accuracy, sensitivity, specificity) of the ImmunoCAP system and the AllergyScreen system were 0.810 and 0.819, 0.872 and 0.780, 0.741 and 0.862 respectively. The accuracy was similar between the two systems (χ(2) = 0.112, P > 0.05). The ImmunoCAP system had a higher sensitivity (χ(2) = 7.361, P < 0.05). The AllergyScreen system had a higher specificity (χ(2) = 10.222, P < 0.05).
This data supported the use of ImmunoCAP system and AllergyScreen system to identify potentially significant individual allergens in the diagnosis of allergic rhinitis. The ImmunoCAP system had a higher sensitivity. The AllergyScreen system had a higher specificity. The AllergyScreen system can be used as a complementary with the ImmunoCAP system.
评估两种血清特异性IgE与皮肤点刺试验(SPT)在变应性鼻炎诊断中的相关性。
2009年6月至10月,216例疑似变应性鼻炎患者被转诊至过敏症专科医生处。如果患者有阳性临床病史且针对疑似吸入性变应原的SPT相关结果为阳性,则被分类为吸入性过敏阳性。使用SPSS13.0软件进行统计分析。
158例患者SPT结果为阳性,与SPT相比,ImmunoCAP系统和AllergyScreen系统的诊断指标(准确性、敏感性、特异性)分别为0.810和0.819、0.872和0.780、0.741和0.862。两种系统的准确性相似(χ(2)=0.112,P>0.05)。ImmunoCAP系统具有更高的敏感性(χ(2)=7.361,P<0.05)。AllergyScreen系统具有更高的特异性(χ(2)=10.222,P<0.05)。
该数据支持在变应性鼻炎诊断中使用ImmunoCAP系统和AllergyScreen系统来识别潜在的重要个体变应原。ImmunoCAP系统具有更高的敏感性。AllergyScreen系统具有更高的特异性。AllergyScreen系统可作为ImmunoCAP系统的补充。